Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT061 in moderate to severe chronic plaque psoriasis
NCT01072383Phase 2Completed
- Sponsor
- Biotest AG
- Start
- Feb 2010
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of tregalizumab in plaque psoriasis, sponsored by Biotest AG. Started Feb 2010; status: completed.
02
Drugs
tregalizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01072383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01072383.